Precision BioSciences (NASDAQ:DTIL) reported quarterly losses of $(2.22) per share which missed the analyst consensus estimate of $(1.96) by 13.27 percent. This is a 45.32 percent increase over losses of $(4.06) per share from the same period last year. The company reported quarterly sales of $638.00 thousand which missed the analyst consensus estimate of $4.28 million by 85.08 percent. This is a 90.93 percent decrease over sales of $7.04 million the same period last year.